Atlas Trials

Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Clinical trial NCT01665014 · UNKNOWN

Trial details

NCT number
NCT01665014
Sponsor
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2012-08-01
Primary completion
2015-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.